Robeco Institutional Asset Management B.V. Purchases 25,342 Shares of Danaher Co. (DHR)

Robeco Institutional Asset Management B.V. lifted its position in shares of Danaher Co. (NYSE:DHR) by 22.2% in the 1st quarter, Holdings Channel reports. The fund owned 139,354 shares of the conglomerate’s stock after buying an additional 25,342 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Danaher were worth $18,396,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in the company. HL Financial Services LLC lifted its holdings in Danaher by 0.4% in the 1st quarter. HL Financial Services LLC now owns 19,148 shares of the conglomerate’s stock valued at $2,528,000 after acquiring an additional 79 shares during the last quarter. First Personal Financial Services lifted its holdings in Danaher by 13.7% in the 1st quarter. First Personal Financial Services now owns 664 shares of the conglomerate’s stock valued at $88,000 after acquiring an additional 80 shares during the last quarter. Carroll Financial Associates Inc. lifted its holdings in Danaher by 5.6% in the 1st quarter. Carroll Financial Associates Inc. now owns 1,534 shares of the conglomerate’s stock valued at $202,000 after acquiring an additional 82 shares during the last quarter. Cookson Peirce & Co. Inc. lifted its holdings in Danaher by 1.8% in the 1st quarter. Cookson Peirce & Co. Inc. now owns 4,710 shares of the conglomerate’s stock valued at $622,000 after acquiring an additional 83 shares during the last quarter. Finally, Appleton Partners Inc. MA lifted its holdings in Danaher by 1.4% in the 1st quarter. Appleton Partners Inc. MA now owns 6,434 shares of the conglomerate’s stock valued at $849,000 after acquiring an additional 90 shares during the last quarter. Institutional investors and hedge funds own 77.57% of the company’s stock.

In other news, Director Walter G. Lohr sold 10,578 shares of the company’s stock in a transaction dated Wednesday, February 27th. The stock was sold at an average price of $126.85, for a total value of $1,341,819.30. Following the transaction, the director now owns 20,691 shares in the company, valued at approximately $2,624,653.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 183,878 shares of the company’s stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $131.30, for a total value of $24,143,181.40. Following the completion of the transaction, the chief executive officer now owns 302,377 shares in the company, valued at approximately $39,702,100.10. The disclosure for this sale can be found here. Insiders sold a total of 424,761 shares of company stock worth $54,983,097 in the last quarter. 11.40% of the stock is owned by corporate insiders.



A number of analysts have commented on DHR shares. Janney Montgomery Scott raised shares of Danaher from a “neutral” rating to a “buy” rating in a research note on Monday, February 25th. UBS Group upped their price objective on shares of Danaher from $125.00 to $144.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Deutsche Bank upped their price objective on shares of Danaher to $130.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Jefferies Financial Group upped their price objective on shares of Danaher to $140.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $138.00 price objective (up from $114.00) on shares of Danaher in a research note on Thursday, February 28th. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $131.75.

DHR stock opened at $129.46 on Tuesday. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32. Danaher Co. has a one year low of $94.59 and a one year high of $134.67. The stock has a market cap of $94.27 billion, a price-to-earnings ratio of 28.64, a PEG ratio of 2.54 and a beta of 1.02.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.01 by $0.06. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The company had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.80 billion. During the same period in the prior year, the firm earned $0.99 earnings per share. The business’s quarterly revenue was up 3.9% on a year-over-year basis. Sell-side analysts predict that Danaher Co. will post 4.77 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date is Thursday, June 27th. Danaher’s dividend payout ratio is presently 15.04%.

COPYRIGHT VIOLATION WARNING: “Robeco Institutional Asset Management B.V. Purchases 25,342 Shares of Danaher Co. (DHR)” was first posted by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://dakotafinancialnews.com/2019/05/14/robeco-institutional-asset-management-b-v-purchases-25342-shares-of-danaher-co-dhr.html.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

See Also: Why is cost of goods sold important?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.